JZP598
JZP598-206
Phase 2 small_molecule active
Quick answer
JZP598 for Patients with HER2-expressing solid tumors is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals Ireland Limited
- Indication
- Patients with HER2-expressing solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active